
Cost-effectiveness analysis of etanercept plus methotrexate vs triple therapy in treating Chinese rheumatoid arthritis patients
Author(s) -
Zhichao Shi,
Hong-Ping Fei,
Zhiliang Wang
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000016635
Subject(s) - medicine , etanercept , rheumatoid arthritis , methotrexate , erythrocyte sedimentation rate , cost effectiveness analysis , cost effectiveness , gastroenterology , risk analysis (engineering)